cAMPfield Therapeutics
PrivateLast Round
Series A
Jun 18, 2026
Total Funding Raised
$360M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
cAMPfield Therapeutics is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for the treatment of inflammatory bowel disease (IBD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
cAMPfield Therapeutics Comparables
Compare cAMPfield Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Palisade Bio | 79% | |
| Abivax | 74% | |
| Ventyx Biosciences | 74% | |
cAMPfield Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 18, 2026 | ||||
| Series A | May 20, 2026 |
cAMPfield Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| RA Capital Management | Series A |
| Mountainfield Venture Partners | Series A |
| Forbion | Series A |
| Deep Track Capital | Series A |
| Frazier Life Sciences | Series A |
| Abingworth | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$180M round with participation from RA Capital Management.
- May 20, 2026
$180M round led by Mountainfield Venture Partners.
cAMPfield Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about cAMPfield Therapeutics's valuation, stock price, and market status.